Copper Zinc Antimony Sulfide (CZAS) is derived from Copper AntimonySulfide (CAS), a famatinite class of compound. In the current paper, thefirst step for using Copper, Zinc, Antimony and Sulfide as materials inmanufacturing synchrotronic biosensor-namely increasing the sensitivity of biosensor through creating Copper Zinc Antimony Sulfide, CZAS(Cu1.18Zn0.40Sb1.90S7.2) semiconductor and using it instead of CopperTin Sulfide, CTS (Cu2SnS3) for tracking, monitoring, imaging, measuring,diagnosing and detecting cancer cells, is evaluated. Further, optimization oftris(2,2'-bipyridyl)ruthenium(II)(Ru(bpy)32+) concentrations and CopperZinc Antimony Sulfide, CZAS (Cu1.18Zn0.40Sb1.90S7.2) semiconductor as two main and effective materials in the intensity of synchrotron fortracking, monitoring, imaging, measuring, diagnosing and detecting cancercells are considered so that the highest sensitivity obtains. In this regard,various concentrations of two materials were prepared and photon emissionwas investigated in the absence of cancer cells. On the other hand, ccancerdiagnosis requires the analysis of images and attributes as well as collectingmany clinical and mammography variables. In diagnosis of cancer, it isimportant to determine whether a tumor is benign or malignant. The information about cancer risk prediction along with the type of tumor are crucialfor patients and effective medical decision making. An ideal diagnosticsystem could effectively distinguish between benign and malignant cells;however, such a system has not been created yet. In this study, a model isdeveloped to improve the prediction probability of cancer. It is necessary tohave such a prediction model as the survival probability of cancer is highwhen patients are diagnosed at early stages.